Skip to main content

Table 1 General characteristics of the cohort, n = 91

From: Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study

 

Mean ± SD, median (25th–75th percentiles) or n (%)

Age, in years

53.9 ± 6.1

Sex, male

46 (50.6)

Ethnicity

 Caucasian

67/87 (77.0)

 African

8/87 (9.2)

 Asian

3/87 (3.5)

 Latin-American

3/87 (3.5)

 Other

6/87 (6.9)

BMI, in kg/m2

30.5 ± 5.4

Smoking status

 Current

4 (4.4)

 Ex

48 (52.8)

 Never

39 (42.9)

Level of educationa

 Low

33/79 (41.8)

 Medium

27/79 (34.2)

 High

9/79 (11.4)

At least one comorbidityb

57 (63.3)

Comorbidities

 Heart failure

6 (6.6)

 Renal failure

5 (5.5)

 Diabetes

13 (14.3)

 COPD

6 (6.6)

 Asthma

15 (16.5)

Cardiovascular disease

 

Hospitalized

81 (89.0)

Hospitalization duration, in days

8.0 (4.0, 15.0)

Admitted to ICU

25 (27.5)

Time since infectionc, in days

167.6 ± 35.9

Acute COVID-19 severityd

 Mild

10 (11.0)

 Moderate

59 (64.8)

 Severe

22 (24.2)

  1. BMI Body Mass Index, COPD Chronic Obstructive Pulmonary Disease, ICU Intensive Care Unit
  2. a. Low = MBO or high school; medium = HBO; high = University bachelor or master
  3. b. Measured comorbidities are COPD, asthma, interstitial lung disease, thrombosis, heart failure, renal failure, hepatic disease, diabetes, cancer, rheumatic disease, CVD and neurologic disease
  4. c. Time between infection and study visit 1
  5. d. According to the WHO definition